InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by RUFFOLO ROBERT R, Director. Officer active across 1 companies, notably Sigilon Therapeutics, Inc.. Aggregated, 2 filings have been recorded. The latest transaction was disclosed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€3,2486,750 shares@ €0.4812100.0% of flow
Common Stock
SEC:0001415889-21-003398·
€3,2486,750 shares@ €0.481250.0% of flow
Common Stock
SEC:0001415889-21-003398:0·
2 of 2 declarations
About RUFFOLO ROBERT R
Robert R. Ruffolo is a Director of Sigilon Therapeutics, Inc. In this role, he contributes to the strategic direction of the company and oversight of its operations. His expertise in the biopharmaceutical sector is essential for guiding Sigilon Therapeutics towards its performance and innovation objectives. He is committed to ensuring good governance and accountability within the board.
